Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
CNS Neurosci Ther. 2024 Feb;30(2):e14597. doi: 10.1111/cns.14597.
The neuroprotective effect of magnesium has been widely discussed, and its effectiveness has been confirmed by animal and clinical trials. However, there are still difficulties in clinical translation in diseases such as cerebral ischemia and subarachnoid hemorrhage. Therefore, it is necessary to analyze the literatures about neuroprotection of magnesium to reveal a more comprehensive knowledge framework, research hotspots and trends in the future.
Original articles and reviews related to neuroprotective effects of magnesium from 1999 to 2022 were retrieved from the Web of Science Core Collection (WoSCC). The bibliometrics CiteSpace 6.2.R4 software was used to conduct co-occurrence/co-citation network analysis and plot knowledge visualization maps.
A total of 762 articles from 216 institutions in 64 countries were included in this study. The United States had the largest number of publications, followed by China and Canada. The University of California, UDICE-French Research Universities, and the University of Adelaide were the top three institutions in publication volume. Crowther Caroline A was the most published and cited author. Among the top 10 cited articles, there were seven articles on neuroprotection in preterm infants and three on acute stroke. Keyword cluster analysis obtained 11 clusters, showing that current research hotspots focused on magnesium therapy in neurovascular diseases such as cerebral ischemia, spinal cord injury, subarachnoid hemorrhage, and emerging treatment strategies.
The neuroprotective effects of magnesium in preterm infants have been extensively studied and adequately confirmed. The therapeutic effects of magnesium on cerebral ischemia and subarachnoid hemorrhage have been demonstrated in animal models. However, the results of clinical studies were not satisfactory, and exploring new therapeutic strategies may be the solution. Recently, the combination of magnesium and hypothermia had great potential in neuroprotective therapy and may become a development trend and hotspot in the future.
镁的神经保护作用已得到广泛讨论,动物实验和临床试验证实了其有效性。然而,在脑缺血和蛛网膜下腔出血等疾病的临床转化中仍存在困难。因此,有必要对镁的神经保护作用相关文献进行分析,以揭示更全面的知识框架、研究热点和未来趋势。
从 Web of Science 核心合集(WoSCC)中检索了 1999 年至 2022 年间与镁的神经保护作用相关的原始文章和综述。使用文献计量学 CiteSpace 6.2.R4 软件进行共现/共被引网络分析和绘制知识可视化图谱。
本研究共纳入来自 64 个国家的 216 个机构的 762 篇文章。美国发表的文章数量最多,其次是中国和加拿大。在发表数量方面,加利福尼亚大学、UDICE-法国研究型大学和阿德莱德大学位列前三。发表和引用量最高的作者是 Crowther Caroline A。在被引次数最多的 10 篇文章中,有 7 篇关于早产儿的神经保护作用,3 篇关于急性中风。关键词聚类分析得到 11 个聚类,表明当前的研究热点集中在脑缺血、脊髓损伤、蛛网膜下腔出血等神经血管疾病的镁治疗以及新兴治疗策略上。
镁对早产儿的神经保护作用已得到广泛研究和充分证实。镁对动物模型脑缺血和蛛网膜下腔出血的治疗效果已得到证实。然而,临床研究的结果并不令人满意,探索新的治疗策略可能是解决问题的方法。最近,镁与低温联合治疗在神经保护治疗中具有巨大潜力,可能成为未来的发展趋势和热点。